Placental effects of lead in mice.
Although a number of studies in animal models have shown embryolethal and teratogenic lead effects when this element is administered by a parenteral route, the mechanism of the embryonary changes is well not established. In this study, the embryonic effects of parenteral lead exposure on day 9 of gestation were assessed in the Swiss mouse. Lead acetate trihydrate was injected intraperitoneally at 14, 28, 56 and 112 mg/kg. There was no maternal toxicity evidenced by death, reduced body weight gain or reduced food consumption. However, absolute placental weight at 112 mg/kg and relative placental weight at 14, 56 and 112 mg/kg were diminished significantly. The number of total implants, live and dead fetuses, sex ratio and fetal body weight were unaffected by lead exposure. Most sections of placenta showed vascular congestion, an increase of intracellular spaces and deposits of hyaline material of perivascular predominance. Trophoblast hyperplasia was also observed, whereas there was a reinforcement of the fibrovascular network in the labyrinth. It is concluded that the trophoblast hyperplasia observed in the placenta of pregnant mice after parenteral lead exposure at doses that are not toxic for the dam could act as a repairing mechanism of the extraembryonary tissues.
Fuentes
M
M
Department of Public Health and Policy, University of Barcelona, Spain.
Torregrosa
A
A
Mora
R
R
Götzens
V
V
Corbellla
J
J
Domingo
J L
JL
D000818:Animals; D005260:Female; D005333:Fetus / Q000187:drug effects; D006965:Hyperplasia; D051379:Mice; D009929:Organ Size / Q000187:drug effects; D009942:Organometallic Compounds / Q000494:pharmacology* / Q000633:toxicity; D010920:Placenta / Q000187:drug effects* / Q000473:pathology; D011247:Pregnancy; D015430:Weight Gain / Q000187:drug effects
D009942:Organometallic Compounds; C008261:lead acetate